Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Circassia Pharmaceuticals Plc (CIR.LN)

Circassia Pharmaceuticals Plc (CIR.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Circassia Pharmaceuticals Plc Edmund Halley Road Hayakawa Building Oxford OX4 4GB GBR

Description:

Circassia Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the Aisa Pacific and also has a presence in the EU, US, and Rest of world.

Key Statistics

Overview:

Market Capitalization, $K 142,656
Shares Outstanding, K 419,578
Annual Sales, $ 27,900 K
Annual Net Income, $ 3,600 K
% of Insider Shareholders 3.25%
% of Institutional Shareholders 7.56%

Growth:

1-Year Return -11.34%
3-Year Return 107.95%
5-Year Return -61.36%
5-Year Revenue Growth 3.85%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.01
Dividend Payout Ratio 0.00%

CIR.LN Ratios

Ratio
Price/Earnings ttm 34.00
Price/Earnings forward 42.55
Return-on-Equity % 5.42%
Return-on-Assets % 3.80%
Profit Margin % 12.90%
Debt/Equity 0.01
Price/Sales 5.31
Price/Book 2.14
Book Value/Share 0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar